Morgan Stanley’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-540
Closed -$394 8144
2023
Q4
$394 Buy
540
+270
+100% +$197 ﹤0.01% 7302
2023
Q3
$303 Hold
270
﹤0.01% 7357
2023
Q2
$364 Sell
270
-1,199
-82% -$1.62K ﹤0.01% 7404
2023
Q1
$1.56K Sell
1,469
-31
-2% -$33 ﹤0.01% 7283
2022
Q4
$3.53K Buy
1,500
+31
+2% +$73 ﹤0.01% 7241
2022
Q3
$6K Buy
1,469
+315
+27% +$1.29K ﹤0.01% 7235
2022
Q2
$5K Buy
1,154
+3
+0.3% +$13 ﹤0.01% 7432
2022
Q1
$10K Sell
1,151
-1
-0.1% -$9 ﹤0.01% 7426
2021
Q4
$13K Buy
1,152
+1
+0.1% +$11 ﹤0.01% 7404
2021
Q3
$20K Sell
1,151
-877
-43% -$15.2K ﹤0.01% 7109
2021
Q2
$38K Buy
2,028
+1,903
+1,522% +$35.7K ﹤0.01% 6790
2021
Q1
$3K Buy
125
+119
+1,983% +$2.86K ﹤0.01% 7246
2020
Q4
$0 Hold
6
﹤0.01% 7301
2020
Q3
$0 Hold
6
﹤0.01% 6994
2020
Q2
$0 Hold
6
﹤0.01% 6916
2020
Q1
$0 Hold
6
﹤0.01% 6946
2019
Q4
$1K Hold
6
﹤0.01% 6628
2019
Q3
$2K Hold
6
﹤0.01% 6524
2019
Q2
$4K Hold
6
﹤0.01% 6384
2019
Q1
$7K Sell
6
-1
-14% -$1.17K ﹤0.01% 6280
2018
Q4
$8K Sell
7
-1
-13% -$1.14K ﹤0.01% 6229
2018
Q3
$12K Sell
8
-2
-20% -$3K ﹤0.01% 6279
2018
Q2
$13K Buy
10
+2
+25% +$2.6K ﹤0.01% 6257
2018
Q1
$77K Hold
8
﹤0.01% 5779
2017
Q4
$115K Sell
8
-5
-38% -$71.9K ﹤0.01% 5602
2017
Q3
$341K Sell
13
-2
-13% -$52.5K ﹤0.01% 5096
2017
Q2
$762K Buy
15
+3
+25% +$152K ﹤0.01% 4566
2017
Q1
$885K Sell
12
-1
-8% -$73.8K ﹤0.01% 4472
2016
Q4
$1.03M Buy
13
+6
+86% +$475K ﹤0.01% 4441
2016
Q3
$915K Sell
7
-1
-13% -$131K ﹤0.01% 4106
2016
Q2
$849K Hold
8
﹤0.01% 4101
2016
Q1
$1.06M Buy
8
+3
+60% +$398K ﹤0.01% 3884
2015
Q4
$708K Buy
5
+1
+25% +$142K ﹤0.01% 4300
2015
Q3
$698K Hold
4
﹤0.01% 4385
2015
Q2
$1.17M Buy
+4
New +$1.17M ﹤0.01% 4077